EXCEDRIN EXTRA STRENGTH - acetaminophen, aspirin and caffeine tablet, film coated 
Novartis Consumer Health, Inc.

----------

DRUG FACTS

Active ingredient (in each tablet)

Acetaminophen 250 mg

Aspirin 250 mg (NSAID)*

Caffeine 65 mg

*nonsteroidal anti-inflammatory drug

Purpose

Pain reliever

Pain reliever

Pain reliever aid

Uses

Warnings

Reye’s syndrome:

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.

Allergy alert:

Aspirin may cause a severe allergic reaction which may include:

Liver warning:

This product contains acetaminophen. Severe liver damage may occur if you take

 

Stomach bleeding warning:

This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding. The chance is higher if you

 

Caffeine warning: 

The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat.

Do not use

Ask Doctor before use if

Ask a doctor or pharmacist before use

 

Stop use and ask doctor if

If pregnant or breast-feeding

ask a health professional before use. It is especially important not to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children

Overdose Warning

In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions

Other information 

 

Inactive ingredients

benzoic acid, carnauba wax, FD&C blue #1, hydroxypropylcellulose, hypromellose, light mineral oil, microcrystalline cellulose, polysorbate 20, povidone, propylene glycol, simethicone emulsion, sorbitan monolaurate, stearic acid, titanium dioxide

Principal Display Panel

Excedrin E.S. Tablets


EXCEDRIN  EXTRA STRENGTH
acetaminophen, aspirin (nsaid), and caffeine   tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)0067-2030
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN250 mg
ASPIRIN (ASPIRIN) ASPIRIN250 mg
CAFFEINE (CAFFEINE) CAFFEINE65 mg
Inactive Ingredients
Ingredient NameStrength
BENZOIC ACID 
CARNAUBA WAX 
CELLULOSE, MICROCRYSTALLINE 
FD&C BLUE NO. 1 
HYDROXYPROPYL CELLULOSE 
HYPROMELLOSE 
LIGHT MINERAL OIL 
POLYSORBATE 20 
COPOVIDONE 
POVIDONE 
PROPYLENE GLYCOL 
SORBITAN MONOLAURATE 
TITANIUM DIOXIDE 
Product Characteristics
ColorWHITE (White) Score no score
ShapeROUNDSize11mm
FlavorImprint Code E
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
10067-2030-061 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
16 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-06)
20067-2030-081 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
28 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-08)
30067-2030-101 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
310 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-10)
40067-2030-241 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
424 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-24)
50067-2030-501 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
550 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-50)
60067-2030-911 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
6100 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-91)
70067-2030-94100 TABLET In 1 BOTTLE, PLASTICNone
80067-2030-831 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
8125 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-83)
90067-2030-921 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
9200 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-92)
100067-2030-5150 PACKET In 1 BOX, UNIT-DOSEcontains a PACKET (0067-2030-02)
100067-2030-022 TABLET In 1 PACKETThis package is contained within the BOX, UNIT-DOSE (0067-2030-51)
110067-2030-07250 TABLET In 1 BOTTLE, PLASTICNone
120067-2030-771 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
12250 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-77)
130067-2030-331 BOTTLE In 1 CARTONcontains a BOTTLE, PLASTIC
13300 TABLET In 1 BOTTLE, PLASTICThis package is contained within the CARTON (0067-2030-33)

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34309/27/2006

Labeler - Novartis Consumer Health, Inc. (879821635)
Establishment
NameAddressID/FEIOperations
Novartis Consumer Health129836151MANUFACTURE, ANALYSIS
Revised: 08/2009Novartis Consumer Health, Inc.